(S)-(4-(5-bromopicolinoyl)-3-(4-chlorophenyl)piperazin-1-yl)(6-bromopyrazolo[1,5-a]pyridin-3-yl)methanone

ID: ALA4168783

Chembl Id: CHEMBL4168783

PubChem CID: 145952791

Max Phase: Preclinical

Molecular Formula: C24H18Br2ClN5O2

Molecular Weight: 603.70

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1cnn2cc(Br)ccc12)N1CCN(C(=O)c2ccc(Br)cn2)[C@@H](c2ccc(Cl)cc2)C1

Standard InChI:  InChI=1S/C24H18Br2ClN5O2/c25-16-3-7-20(28-11-16)24(34)31-10-9-30(14-22(31)15-1-5-18(27)6-2-15)23(33)19-12-29-32-13-17(26)4-8-21(19)32/h1-8,11-13,22H,9-10,14H2/t22-/m1/s1

Standard InChI Key:  NXUPTMOYEVVJFX-JOCHJYFZSA-N

Alternative Forms

  1. Parent:

    ALA4168783

    ---

Associated Targets(Human)

EIF4A3 Tchem Eukaryotic initiation factor 4A-III (131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 603.70Molecular Weight (Monoisotopic): 600.9516AlogP: 5.25#Rotatable Bonds: 3
Polar Surface Area: 70.81Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 0.96CX LogP: 4.82CX LogD: 4.82
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.32Np Likeness Score: -1.72

References

1. Mizojiri R, Nakata D, Satoh Y, Morishita D, Shibata S, Iwatani-Yoshihara M, Kosugi Y, Kosaka M, Takeda J, Sasaki S, Takami K, Fukuda K, Kamaura M, Sasaki S, Arai R, Cary DR, Imaeda Y..  (2017)  Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1H)-one Derivatives as Orally eIF4A3-Selective Inhibitors.,  (10): [PMID:29057054] [10.1021/acsmedchemlett.7b00283]

Source